Biocon settles US patent dispute with Roche’s Genentech, eyes 2027 Perjeta biosimilar launch
Roche's Genentech has settled a US lawsuit towards Indian biopharmaceutical firm Biocon over its proposed biosimilar of Genentech's blockbuster breast-cancer ...